nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—HTR2A—Alzheimer's disease	0.478	1	CbGaD
Cyamemazine—HTR2A—Donepezil—Alzheimer's disease	0.388	1	CbGbCtD
Cyamemazine—HTR2C—choroid plexus—Alzheimer's disease	0.0305	0.303	CbGeAlD
Cyamemazine—HTR2A—choroid plexus—Alzheimer's disease	0.0153	0.152	CbGeAlD
Cyamemazine—HTR2A—locus ceruleus—Alzheimer's disease	0.00946	0.0939	CbGeAlD
Cyamemazine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00894	0.0888	CbGeAlD
Cyamemazine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00771	0.0765	CbGeAlD
Cyamemazine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00449	0.0445	CbGeAlD
Cyamemazine—CHRM2—forebrain—Alzheimer's disease	0.00242	0.024	CbGeAlD
Cyamemazine—HTR2C—forebrain—Alzheimer's disease	0.00233	0.0232	CbGeAlD
Cyamemazine—CHRM2—telencephalon—Alzheimer's disease	0.00223	0.0221	CbGeAlD
Cyamemazine—HTR2A—blood vessel—Alzheimer's disease	0.00222	0.022	CbGeAlD
Cyamemazine—HTR2C—telencephalon—Alzheimer's disease	0.00215	0.0213	CbGeAlD
Cyamemazine—HTR2A—embryo—Alzheimer's disease	0.00132	0.0131	CbGeAlD
Cyamemazine—CHRM2—nervous system—Alzheimer's disease	0.00132	0.0131	CbGeAlD
Cyamemazine—HTR2C—nervous system—Alzheimer's disease	0.00127	0.0126	CbGeAlD
Cyamemazine—CHRM2—central nervous system—Alzheimer's disease	0.00127	0.0126	CbGeAlD
Cyamemazine—HTR2C—central nervous system—Alzheimer's disease	0.00122	0.0121	CbGeAlD
Cyamemazine—HTR2A—forebrain—Alzheimer's disease	0.00117	0.0116	CbGeAlD
Cyamemazine—HTR2A—telencephalon—Alzheimer's disease	0.00108	0.0107	CbGeAlD
Cyamemazine—CHRM2—brain—Alzheimer's disease	0.00101	0.00998	CbGeAlD
Cyamemazine—HTR2C—brain—Alzheimer's disease	0.000969	0.00962	CbGeAlD
Cyamemazine—Dimetacrine—ACHE—Alzheimer's disease	0.000662	0.0884	CrCbGaD
Cyamemazine—HTR2A—nervous system—Alzheimer's disease	0.000636	0.00631	CbGeAlD
Cyamemazine—HTR2A—central nervous system—Alzheimer's disease	0.000612	0.00608	CbGeAlD
Cyamemazine—HTR2A—cerebellum—Alzheimer's disease	0.000598	0.00594	CbGeAlD
Cyamemazine—HTR2A—brain—Alzheimer's disease	0.000486	0.00482	CbGeAlD
Cyamemazine—Mesoridazine—HTR6—Alzheimer's disease	0.000339	0.0453	CrCbGaD
Cyamemazine—Fluphenazine—CALM1—Alzheimer's disease	0.000329	0.044	CrCbGaD
Cyamemazine—Fluphenazine—HTR6—Alzheimer's disease	0.000297	0.0397	CrCbGaD
Cyamemazine—Clomipramine—HTR6—Alzheimer's disease	0.000272	0.0363	CrCbGaD
Cyamemazine—Chlorprothixene—HTR6—Alzheimer's disease	0.000271	0.0361	CrCbGaD
Cyamemazine—Promethazine—CALM1—Alzheimer's disease	0.000267	0.0356	CrCbGaD
Cyamemazine—Trifluoperazine—CALM1—Alzheimer's disease	0.000263	0.0351	CrCbGaD
Cyamemazine—Perphenazine—CALM1—Alzheimer's disease	0.00026	0.0348	CrCbGaD
Cyamemazine—Thioridazine—HTR6—Alzheimer's disease	0.000256	0.0342	CrCbGaD
Cyamemazine—Trifluoperazine—HTR6—Alzheimer's disease	0.000238	0.0317	CrCbGaD
Cyamemazine—Perphenazine—HTR6—Alzheimer's disease	0.000235	0.0314	CrCbGaD
Cyamemazine—Ethopropazine—BCHE—Alzheimer's disease	0.000231	0.0309	CrCbGaD
Cyamemazine—Chlorpromazine—CALM1—Alzheimer's disease	0.000207	0.0276	CrCbGaD
Cyamemazine—Triflupromazine—BCHE—Alzheimer's disease	0.000189	0.0253	CrCbGaD
Cyamemazine—Chlorpromazine—HTR6—Alzheimer's disease	0.000186	0.0249	CrCbGaD
Cyamemazine—Imipramine—HTR6—Alzheimer's disease	0.000185	0.0247	CrCbGaD
Cyamemazine—Mequitazine—CYP2D6—Alzheimer's disease	0.00013	0.0174	CrCbGaD
Cyamemazine—Diltiazem—CYP2D6—Alzheimer's disease	0.000117	0.0156	CrCbGaD
Cyamemazine—Acepromazine—HTR2A—Alzheimer's disease	0.000105	0.014	CrCbGaD
Cyamemazine—Clomipramine—SLC6A4—Alzheimer's disease	0.000104	0.0139	CrCbGaD
Cyamemazine—Thioproperazine—HTR2A—Alzheimer's disease	0.000103	0.0137	CrCbGaD
Cyamemazine—Pipotiazine—HTR2A—Alzheimer's disease	0.000101	0.0135	CrCbGaD
Cyamemazine—Mesoridazine—HTR2A—Alzheimer's disease	9.98e-05	0.0133	CrCbGaD
Cyamemazine—Trimipramine—SLC6A4—Alzheimer's disease	9.57e-05	0.0128	CrCbGaD
Cyamemazine—Pipotiazine—CYP2D6—Alzheimer's disease	9.25e-05	0.0123	CrCbGaD
Cyamemazine—Chlorpromazine—BCHE—Alzheimer's disease	9.14e-05	0.0122	CrCbGaD
Cyamemazine—Mesoridazine—CYP2D6—Alzheimer's disease	9.13e-05	0.0122	CrCbGaD
Cyamemazine—Prochlorperazine—CYP2D6—Alzheimer's disease	8.84e-05	0.0118	CrCbGaD
Cyamemazine—Fluphenazine—HTR2A—Alzheimer's disease	8.74e-05	0.0117	CrCbGaD
Cyamemazine—Propiomazine—HTR2A—Alzheimer's disease	8.41e-05	0.0112	CrCbGaD
Cyamemazine—Clomipramine—HTR2A—Alzheimer's disease	7.99e-05	0.0107	CrCbGaD
Cyamemazine—Fluphenazine—CYP2D6—Alzheimer's disease	7.99e-05	0.0107	CrCbGaD
Cyamemazine—Chlorprothixene—HTR2A—Alzheimer's disease	7.96e-05	0.0106	CrCbGaD
Cyamemazine—Thioridazine—HTR2A—Alzheimer's disease	7.53e-05	0.0101	CrCbGaD
Cyamemazine—Trimipramine—HTR2A—Alzheimer's disease	7.36e-05	0.00982	CrCbGaD
Cyamemazine—Clomipramine—CYP2D6—Alzheimer's disease	7.31e-05	0.00976	CrCbGaD
Cyamemazine—Methotrimeprazine—HTR2A—Alzheimer's disease	7.19e-05	0.0096	CrCbGaD
Cyamemazine—Imipramine—SLC6A4—Alzheimer's disease	7.1e-05	0.00947	CrCbGaD
Cyamemazine—Promethazine—HTR2A—Alzheimer's disease	7.08e-05	0.00945	CrCbGaD
Cyamemazine—Trifluoperazine—HTR2A—Alzheimer's disease	6.99e-05	0.00933	CrCbGaD
Cyamemazine—Perphenazine—HTR2A—Alzheimer's disease	6.91e-05	0.00922	CrCbGaD
Cyamemazine—Thioridazine—CYP2D6—Alzheimer's disease	6.89e-05	0.00919	CrCbGaD
Cyamemazine—Trimipramine—CYP2D6—Alzheimer's disease	6.73e-05	0.00898	CrCbGaD
Cyamemazine—Methotrimeprazine—CYP2D6—Alzheimer's disease	6.58e-05	0.00878	CrCbGaD
Cyamemazine—Promethazine—CYP2D6—Alzheimer's disease	6.48e-05	0.00864	CrCbGaD
Cyamemazine—Perphenazine—CYP2D6—Alzheimer's disease	6.32e-05	0.00844	CrCbGaD
Cyamemazine—Promazine—HTR2A—Alzheimer's disease	6.23e-05	0.00832	CrCbGaD
Cyamemazine—Chlorpromazine—HTR2A—Alzheimer's disease	5.48e-05	0.00732	CrCbGaD
Cyamemazine—Imipramine—HTR2A—Alzheimer's disease	5.46e-05	0.00728	CrCbGaD
Cyamemazine—Chlorpromazine—CYP2D6—Alzheimer's disease	5.01e-05	0.00669	CrCbGaD
Cyamemazine—Imipramine—CYP2D6—Alzheimer's disease	4.99e-05	0.00666	CrCbGaD
Cyamemazine—HTR2C—GPCR downstream signaling—APP—Alzheimer's disease	2.86e-05	0.00111	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CCR5—Alzheimer's disease	2.85e-05	0.00111	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—IAPP—Alzheimer's disease	2.85e-05	0.00111	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PYY—Alzheimer's disease	2.83e-05	0.0011	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CRH—Alzheimer's disease	2.82e-05	0.0011	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	2.8e-05	0.00109	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—NPS—Alzheimer's disease	2.8e-05	0.00109	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—HTR2A—Alzheimer's disease	2.79e-05	0.00109	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.78e-05	0.00108	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CRH—Alzheimer's disease	2.77e-05	0.00108	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HTR6—Alzheimer's disease	2.77e-05	0.00108	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	2.75e-05	0.00107	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.7e-05	0.00105	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—NPS—Alzheimer's disease	2.67e-05	0.00104	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—GAB2—Alzheimer's disease	2.67e-05	0.00104	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—SST—Alzheimer's disease	2.67e-05	0.00104	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—NPY—Alzheimer's disease	2.65e-05	0.00103	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IAPP—Alzheimer's disease	2.64e-05	0.00103	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—NPS—Alzheimer's disease	2.62e-05	0.00102	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—NPY—Alzheimer's disease	2.61e-05	0.00101	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—APP—Alzheimer's disease	2.6e-05	0.00101	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IAPP—Alzheimer's disease	2.59e-05	0.00101	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CCL2—Alzheimer's disease	2.56e-05	0.000996	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CRH—Alzheimer's disease	2.56e-05	0.000996	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—GAB2—Alzheimer's disease	2.55e-05	0.000992	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—SST—Alzheimer's disease	2.55e-05	0.000992	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CRH—Alzheimer's disease	2.51e-05	0.000978	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PSENEN—Alzheimer's disease	2.51e-05	0.000977	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—GAB2—Alzheimer's disease	2.5e-05	0.000974	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—SST—Alzheimer's disease	2.5e-05	0.000974	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CDK5—Alzheimer's disease	2.5e-05	0.000971	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—F2—Alzheimer's disease	2.49e-05	0.00097	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—APP—Alzheimer's disease	2.48e-05	0.000966	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APH1A—Alzheimer's disease	2.48e-05	0.000964	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—PLCB1—Alzheimer's disease	2.45e-05	0.000954	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CDK5—Alzheimer's disease	2.45e-05	0.000953	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—F2—Alzheimer's disease	2.45e-05	0.000953	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—APP—Alzheimer's disease	2.44e-05	0.000949	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—NPS—Alzheimer's disease	2.43e-05	0.000944	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.42e-05	0.000939	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NCSTN—Alzheimer's disease	2.41e-05	0.000938	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—HTR6—Alzheimer's disease	2.4e-05	0.000935	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—NPS—Alzheimer's disease	2.38e-05	0.000927	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.37e-05	0.000922	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HTR6—Alzheimer's disease	2.36e-05	0.000918	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LRP1—Alzheimer's disease	2.35e-05	0.000915	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.34e-05	0.000912	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—GAB2—Alzheimer's disease	2.32e-05	0.000901	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—SST—Alzheimer's disease	2.32e-05	0.000901	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.3e-05	0.000895	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GAL—Alzheimer's disease	2.3e-05	0.000894	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GFAP—Alzheimer's disease	2.3e-05	0.000894	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—GAB2—Alzheimer's disease	2.27e-05	0.000884	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—SST—Alzheimer's disease	2.27e-05	0.000884	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.26e-05	0.00088	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—APP—Alzheimer's disease	2.26e-05	0.000878	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CCL2—Alzheimer's disease	2.22e-05	0.000865	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.22e-05	0.000864	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—APP—Alzheimer's disease	2.22e-05	0.000862	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CCL2—Alzheimer's disease	2.18e-05	0.000849	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PSENEN—Alzheimer's disease	2.18e-05	0.000849	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APH1A—Alzheimer's disease	2.15e-05	0.000837	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PSENEN—Alzheimer's disease	2.14e-05	0.000833	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PLCB1—Alzheimer's disease	2.13e-05	0.000828	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	2.11e-05	0.000822	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NCSTN—Alzheimer's disease	2.1e-05	0.000815	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	2.09e-05	0.000813	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	2.06e-05	0.0008	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LRP1—Alzheimer's disease	2.04e-05	0.000795	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—A2M—Alzheimer's disease	2.03e-05	0.000788	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	2.02e-05	0.000784	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	2.01e-05	0.00078	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—PRKCG—Alzheimer's disease	2e-05	0.000777	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GFAP—Alzheimer's disease	2e-05	0.000776	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GAL—Alzheimer's disease	2e-05	0.000776	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PSEN2—Alzheimer's disease	1.96e-05	0.000763	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	1.96e-05	0.000762	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	1.96e-05	0.000762	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CCR5—Alzheimer's disease	1.89e-05	0.000736	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.85e-05	0.00072	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—PRKCG—Alzheimer's disease	1.81e-05	0.000705	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NPY—Alzheimer's disease	1.81e-05	0.000702	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IAPP—Alzheimer's disease	1.79e-05	0.000698	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—A2M—Alzheimer's disease	1.76e-05	0.000684	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.75e-05	0.000681	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CRH—Alzheimer's disease	1.74e-05	0.000677	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.73e-05	0.000674	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	1.73e-05	0.000672	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCR5—Alzheimer's disease	1.72e-05	0.000668	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PSEN2—Alzheimer's disease	1.7e-05	0.000663	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.7e-05	0.000662	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—HTR2A—Alzheimer's disease	1.68e-05	0.000654	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	1.67e-05	0.000651	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NPS—Alzheimer's disease	1.65e-05	0.000642	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CCR5—Alzheimer's disease	1.64e-05	0.000639	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PPP3CA—Alzheimer's disease	1.64e-05	0.000639	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—F2—Alzheimer's disease	1.62e-05	0.000631	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PTK2B—Alzheimer's disease	1.62e-05	0.00063	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.61e-05	0.000627	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.58e-05	0.000614	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NTRK2—Alzheimer's disease	1.58e-05	0.000613	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GAB2—Alzheimer's disease	1.58e-05	0.000613	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SST—Alzheimer's disease	1.58e-05	0.000613	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PRKCG—Alzheimer's disease	1.57e-05	0.000612	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CALM1—Alzheimer's disease	1.57e-05	0.00061	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NPY—Alzheimer's disease	1.57e-05	0.00061	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GSK3A—Alzheimer's disease	1.56e-05	0.000607	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IAPP—Alzheimer's disease	1.56e-05	0.000606	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.55e-05	0.000601	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	1.54e-05	0.000599	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APP—Alzheimer's disease	1.54e-05	0.000597	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	1.53e-05	0.000595	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CRH—Alzheimer's disease	1.51e-05	0.000588	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCR5—Alzheimer's disease	1.49e-05	0.00058	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	1.49e-05	0.000578	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—F2—Alzheimer's disease	1.47e-05	0.000573	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	1.47e-05	0.00057	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PLCB1—Alzheimer's disease	1.45e-05	0.000563	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NPS—Alzheimer's disease	1.43e-05	0.000558	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.43e-05	0.000558	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PPP3CA—Alzheimer's disease	1.43e-05	0.000555	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—F2—Alzheimer's disease	1.41e-05	0.000548	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	1.41e-05	0.000548	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PTK2B—Alzheimer's disease	1.41e-05	0.000547	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.4e-05	0.000545	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	1.38e-05	0.000538	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	1.38e-05	0.000537	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GAB2—Alzheimer's disease	1.37e-05	0.000532	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SST—Alzheimer's disease	1.37e-05	0.000532	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NTRK2—Alzheimer's disease	1.37e-05	0.000532	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CALM1—Alzheimer's disease	1.36e-05	0.00053	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GSK3A—Alzheimer's disease	1.36e-05	0.000527	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NGFR—Alzheimer's disease	1.35e-05	0.000526	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	1.34e-05	0.000522	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SST—Alzheimer's disease	1.34e-05	0.000522	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	1.34e-05	0.000522	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CREB1—Alzheimer's disease	1.34e-05	0.000522	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	1.34e-05	0.00052	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APP—Alzheimer's disease	1.33e-05	0.000518	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	1.33e-05	0.000518	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADAM10—Alzheimer's disease	1.32e-05	0.000513	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCL2—Alzheimer's disease	1.31e-05	0.000511	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APP—Alzheimer's disease	1.31e-05	0.000509	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—F2—Alzheimer's disease	1.28e-05	0.000498	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PLCB1—Alzheimer's disease	1.26e-05	0.000489	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	1.26e-05	0.000489	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—S100B—Alzheimer's disease	1.25e-05	0.000486	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	1.24e-05	0.00048	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IGF2—Alzheimer's disease	1.19e-05	0.000462	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NGFR—Alzheimer's disease	1.17e-05	0.000456	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CREB1—Alzheimer's disease	1.17e-05	0.000454	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	1.15e-05	0.000448	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IGF1R—Alzheimer's disease	1.15e-05	0.000447	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADAM10—Alzheimer's disease	1.15e-05	0.000446	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	1.15e-05	0.000445	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCL2—Alzheimer's disease	1.14e-05	0.000444	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	1.13e-05	0.000438	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	1.12e-05	0.000436	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LPL—Alzheimer's disease	1.1e-05	0.000429	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MEF2C—Alzheimer's disease	1.09e-05	0.000425	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—S100B—Alzheimer's disease	1.08e-05	0.000422	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PRKCG—Alzheimer's disease	1.07e-05	0.000417	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	1.06e-05	0.000414	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NGF—Alzheimer's disease	1.04e-05	0.000406	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IGF2—Alzheimer's disease	1.03e-05	0.000401	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCR5—Alzheimer's disease	1.02e-05	0.000395	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	1.01e-05	0.000394	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IGF1R—Alzheimer's disease	9.98e-06	0.000388	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HTR2A—Alzheimer's disease	9.93e-06	0.000386	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	9.8e-06	0.000381	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LPL—Alzheimer's disease	9.57e-06	0.000372	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MEF2C—Alzheimer's disease	9.48e-06	0.000369	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	9.39e-06	0.000365	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	9.31e-06	0.000362	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	9.3e-06	0.000362	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CALM1—Alzheimer's disease	9.27e-06	0.00036	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LEP—Alzheimer's disease	9.24e-06	0.000359	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APOE—Alzheimer's disease	9.24e-06	0.000359	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CAV1—Alzheimer's disease	9.15e-06	0.000356	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	9.13e-06	0.000355	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	9.06e-06	0.000352	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	8.9e-06	0.000346	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	8.82e-06	0.000343	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	8.81e-06	0.000343	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—F2—Alzheimer's disease	8.71e-06	0.000339	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	8.65e-06	0.000337	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	8.52e-06	0.000331	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	8.47e-06	0.000329	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	8.05e-06	0.000313	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	8.02e-06	0.000312	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	8.02e-06	0.000312	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	8e-06	0.000311	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	7.95e-06	0.000309	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	7.93e-06	0.000309	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	7.9e-06	0.000307	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—INS—Alzheimer's disease	7.89e-06	0.000307	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	7.87e-06	0.000306	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	7.87e-06	0.000306	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	7.8e-06	0.000303	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	7.76e-06	0.000302	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	7.66e-06	0.000298	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	7.63e-06	0.000297	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—F2—Alzheimer's disease	7.56e-06	0.000294	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	7.52e-06	0.000292	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	7.43e-06	0.000289	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	7.4e-06	0.000288	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	7.27e-06	0.000283	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	6.95e-06	0.00027	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	6.92e-06	0.000269	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	6.89e-06	0.000268	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	6.85e-06	0.000266	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	6.82e-06	0.000265	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	6.76e-06	0.000263	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	6.74e-06	0.000262	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	6.73e-06	0.000262	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	6.63e-06	0.000258	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	6.62e-06	0.000257	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	6.51e-06	0.000253	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	6.01e-06	0.000234	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	5.93e-06	0.000231	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	5.9e-06	0.000229	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	5.87e-06	0.000228	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	5.84e-06	0.000227	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	5.4e-06	0.00021	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	5.38e-06	0.000209	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	5.15e-06	0.0002	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	5.1e-06	0.000198	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	5.07e-06	0.000197	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	5.05e-06	0.000197	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	5.01e-06	0.000195	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	4.98e-06	0.000194	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	4.98e-06	0.000194	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	4.69e-06	0.000182	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	4.68e-06	0.000182	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	4.6e-06	0.000179	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	4.59e-06	0.000179	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	4.57e-06	0.000178	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	4.33e-06	0.000168	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	4.25e-06	0.000165	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	3.97e-06	0.000155	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	3.9e-06	0.000152	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	3.77e-06	0.000146	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	3.45e-06	0.000134	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	3.27e-06	0.000127	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	3.21e-06	0.000125	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	3.18e-06	0.000124	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	2.99e-06	0.000116	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	2.94e-06	0.000114	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	2.76e-06	0.000107	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	2.71e-06	0.000105	CbGpPWpGaD
